AI-Augmented Diagnostic Assessment With ENLIGHT Versus Independent Pathologist Review (ENLIGHT)
This study will evaluate whether artificial intelligence (AI) can enhance clinicians' accuracy, efficiency, and confidence in distinguishing lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) and kidney renal papillary cell carcinoma (KIRP) from kidney renal clear cell carcinoma (KIRC) using digitized pathology slides. These subtype classifications are routinely performed by pathologists but can be challenging and time-consuming, particularly in difficult cases.
During the study, participating clinicians will review lung and kidney pathology slides under three different conditions:
- Unaided Review: Diagnosis without AI assistance.
- AI as Double-Check: The clinician first makes an independent diagnosis, after which the AI-generated diagnosis (prediction only or prediction with explanation) is revealed for review.
- AI as First-Look: The AI-generated diagnosis (prediction only or prediction with explanation) is presented before the clinician begins the review.
Clinicians will be randomly assigned to different review sequences to minimize potential order effects. This study design will enable us to assess the impact of AI assistance on diagnostic accuracy, interpretation time, and clinician confidence.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
- Comportemental: Unaided Review First, Then AI as Double-Check, Then AI as First-Look.
- Comportemental: Unaided Review First, Then AI as First-Look, Then AI as Double-Check.
- Comportemental: AI as Double-Check First, Then AI as First-Look, Then Unaided Review.
- Comportemental: AI as First-Look First, Then AI as Double-Check, Then Unaided Review.
Description détaillée
This study aims to evaluate the effect of artificial intelligence (AI) assistance on clinicians' diagnostic performance in distinguishing lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) and kidney renal papillary cell carcinoma (KIRP) from kidney renal clear cell carcinoma (KIRC) using digitized hematoxylin and eosin (H&E)-stained whole-slide images (WSIs). ENLIGHT (Explainable Neoplasm Learning In Grounded Histology Terms) will serve as the AI system under evaluation. This is a single-session, within-reader, between-case study in which each reader evaluates distinct sets of cases under all study conditions.
The study includes three diagnostic blocks: Block X, in which WSIs are reviewed without AI assistance; Block Y1, in which clinicians make an initial diagnosis before viewing the AI output as a double-check; and Block Y2, in which the AI output is displayed before clinicians begin their review as a first-look aid. Within each AI-assisted block, the prediction-only and prediction-with-explanation sub-blocks are presented in randomized order.
Each participating pathologist will review up to 400 de-identified WSIs (up to 200 lung cancer and up to 200 kidney cancer cases). Readers will be randomly assigned to one of four study arms that differ only in the order in which Blocks X, Y1, and Y2 are completed. For each reader, distinct WSIs will be randomly assigned to the diagnostic conditions so that no WSI is reviewed more than once by the same reader.
- Arm 1 (X -> Y1 -> Y2): Clinicians first complete Block X (Unaided Review), followed by Block Y1 (AI as Double-Check) and then Block Y2 (AI as First-Look).
- Arm 2 (X -> Y2 -> Y1): Clinicians first complete Block X (Unaided Review), followed by Block Y2 (AI as First-Look) and then Block Y1 (AI as Double-Check).
- Arm 3 (Y1 -> Y2 -> X): Clinicians first complete Block Y1 (AI as Double-Check), followed by Block Y2 (AI as First-Look), and then Block X (Unaided Review).
- Arm 4 (Y2 -> Y1 -> X): Clinicians first complete Block Y2 (AI as First-Look), followed by Block Y1 (AI as Double-Check), and then Block X (Unaided Review).
For each case, diagnostic accuracy, time to diagnosis, and diagnostic confidence will be recorded. No reader will review the same WSI under more than one condition, thereby eliminating within-reader recall bias. In parallel, the ENLIGHT model will independently generate diagnostic predictions for all WSIs to enable direct benchmarking of AI performance against pathologists and to evaluate the impact of different AI-assisted workflows on diagnostic performance.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02115
- Harvard Medical School,
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria for Pathology Slides (i.e., Cases):
- Hematoxylin and eosin (H&E)-stained pathology slides
- Final diagnosis confirmed through molecular testing in conjunction with expert pathology evaluation
Exclusion Criteria for Pathology Slides (i.e., Cases):
- Poor-quality or unreadable slides
- Cases used in AI training
Inclusion Criteria for Readers (i.e., Participants):
- Board-certified or board-eligible pathologists
- Willingness to complete both unaided and AI-assisted review sessions
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Diagnostique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Unaided Review First, Then AI as Double-Check, Then AI as First-Look.
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparateur actif: Unaided Review First, Then AI as First-Look, Then AI as Double-Check.
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparateur actif: AI as Double-Check Review First, Then AI as First-Look, Then Unaided Review.
Readers first complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparateur actif: AI as First-Look Review First, Then AI as Double-Check, Then Unaided Review.
Readers first complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Diagnostic performance of cancers
Délai: Periprocedural (at the time of slide review)
|
Performance of clinicians (unaided and AI-assisted) for distinguishing LUAD- LUSC and distinguishing KIRP-KIRC, measured in accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1.
|
Periprocedural (at the time of slide review)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Temps de diagnostic
Délai: Périprocédural (au moment de la révision des diapositives)
|
Le temps moyen (secondes par cas) requis pour finaliser un diagnostic.
|
Périprocédural (au moment de la révision des diapositives)
|
|
Variabilité inter-observatrice
Délai: Périprocédural (au moment de la révision des diapositives)
|
Accord entre les cliniciens dans toutes les conditions, mesuré à l'aide de mesures de fiabilité inter-évaluateurs (par exemple, statistiques Kappa).
|
Périprocédural (au moment de la révision des diapositives)
|
|
Avantage net après l'exposition à l'IA
Délai: Périprocédural (au moment de la révision des diapositives)
|
Le changement global de la précision du diagnostic attribuable à l'assistance de l'IA.
|
Périprocédural (au moment de la révision des diapositives)
|
|
Clinician confidence level
Délai: Periprocedural (at the time of slide review)
|
Self-reported diagnostic confidence recorded for each case.
Scale: 5 - Absolutely Certain; 4 - Mostly Certain; 3 - Unsure; 2 - Very Doubtful; 1 - Random Guess; With 5 being the highest confidence score and 1 being the lowest.
|
Periprocedural (at the time of slide review)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ENLIGHT Study
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .